Sage Therapeutics, Inc. Temporary Equity, Accretion to Redemption Value
Sage Therapeutics, Inc. reported Temporary Equity, Accretion to Redemption Value of -$2.29 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-29.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2016-02-29
- Sage Therapeutics, Inc. temporary equity, accretion to redemption value for the quarter ending 2014-12-31 was $0.00.
- Sage Therapeutics, Inc. temporary equity, accretion to redemption value for the quarter ending 2014-09-30 was -$391.00K.
- Sage Therapeutics, Inc. temporary equity, accretion to redemption value for fiscal 2014 was -$2.29M.
- Sage Therapeutics, Inc. temporary equity, accretion to redemption value for fiscal 2013 was -$7.00K.
| Period end | Temporary Equity, Accretion to Redemption Value 3 month | Temporary Equity, Accretion to Redemption Value 6 month | Temporary Equity, Accretion to Redemption Value 9 month | Temporary Equity, Accretion to Redemption Value 12 month | Temporary Equity, Accretion to Redemption Value 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$391.00K derived: sum of 2 quarters · filed 2016-02-29 | -$2.29M 10-K · filed 2016-02-29 | $2.29M 10-K · filed 2015-03-06 | |
| 2014-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$2.29M 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | -$1.90M 10-Q · filed 2014-08-14 | ||||
| 2013-12-31 | -$7.00K 10-K · filed 2016-02-29 |